These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 17992479

  • 1. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D, Schulte-Witte H.
    Med Klin (Munich); 2007 Nov 15; 102(11):888-92. PubMed ID: 17992479
    [Abstract] [Full Text] [Related]

  • 2. [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].
    Krammer HJ, Kämper H, von Bünau R, Zieseniss E, Stange C, Schlieger F, Clever I, Schulze J.
    Z Gastroenterol; 2006 Aug 15; 44(8):651-6. PubMed ID: 16902895
    [Abstract] [Full Text] [Related]

  • 3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
    Enck P, Zimmermann K, Menke G, Klosterhalfen S.
    Z Gastroenterol; 2009 Feb 15; 47(2):209-14. PubMed ID: 19197823
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M.
    Minerva Gastroenterol Dietol; 2006 Dec 15; 52(4):359-63. PubMed ID: 17108865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC, Croffut RM, Stranahan MC.
    Clin Ther; 2005 Jun 15; 27(6):755-61. PubMed ID: 16117982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Probiotic therapy of the irritable bowel syndrome].
    Enck P, Klosterhalfen S, Martens U.
    Dtsch Med Wochenschr; 2011 Feb 15; 136(8):371-5. PubMed ID: 21332036
    [Abstract] [Full Text] [Related]

  • 12. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial.
    Tromm A, Niewerth U, Khoury M, Baestlein E, Wilhelms G, Schulze J, Stolte M.
    Z Gastroenterol; 2004 May 15; 42(5):365-9. PubMed ID: 15136935
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB.
    Pharmacotherapy; 2008 Apr 15; 28(4):496-505. PubMed ID: 18363533
    [Abstract] [Full Text] [Related]

  • 16. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A, Posserud I, Abrahamsson H, Simrén M.
    Aliment Pharmacol Ther; 2007 Sep 15; 26(6):953-61. PubMed ID: 17767480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.
    Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J.
    Int J Colorectal Dis; 2012 Apr 15; 27(4):467-74. PubMed ID: 22130826
    [Abstract] [Full Text] [Related]

  • 19. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
    Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR.
    Aliment Pharmacol Ther; 2009 Mar 01; 29(5):508-18. PubMed ID: 19053980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.